Sign in

NCT06989502Not yet recruiting

Implementation of the COmmunity HEalth System InnovatiON Project in Low- and Middle- Income Countries

GH Project: NIHR150261 - Implementation of the COmmunity HEalth System InnovatiON Project, COHESION-I

Source: ClinicalTrials.gov · Last updated 25 May 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The COHESION-I project will evaluate the effects of the co-creation intervention (2016 to 2019) and the co-design intervention (2023 to 2024) on improving (a) health system responsiveness, and (b) patient satisfaction, at the primary health care level, in Peru, Nepal and Mozambique, in relation to chronic diseases (hypertension, and diabetes mellitus), as well as specific neglected tropical diseases. Each intervention has been tailored to the context and characteristics of each one of the aforementioned low- and middle-income countries. For this quasi-experimental study, three arms were established: the co-creation (2016 to 2019) + co-design (2023 to 2024) arm; the co-design only (2023 to 2024) arm; and the control group (no intervention; usual care). The evaluation will be composed of four types of evaluations: quantitative; qualitative; economic; and process evaluation

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
2094 (estimated)
First submitted
8 Oct 2024
Start date
17 May 2025
Primary completion date
31 Oct 2026
Lead sponsor
Universidad Peruana Cayetano Heredia
NCT number
NCT06989502

What you commit to

  • Study type: Interventional
  • Planned participants: 2094
  • From 17 May 2025 to the primary completion date, 31 Oct 2026
  • 3 sites in 3 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • \- Diagnosis (or estimated risk) of diabetes mellitus type 2, hypertension, or neurocysticercosis

Other

  • The criteria mentioned above refer solely to the quantitative evaluation. For the other types of evaluation, some different populations will be included (such as healthcare workers, local authorities and other stakeholders).

Who the study is looking for

  • Males or females aged 18 years and over, from the selected sites
  • Having used the health services in the previous three months
  • Diagnosis (or estimated risk) of diabetes mellitus type 2, hypertension, or neurocysticercosis
  • Must be able to listen to radio programs, or other audio material
  • Males or females aged 18 years and over, from the selected sites
  • Having used the health services in the previous three months
  • Must be able to listen to radio programs, or other audio material

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Eduardo Mondlane University
Coordinator of this site? Confirm its status
MaputoMozambiqueUnknown status
B P Koirala Institute of Health Sciences
Coordinator of this site? Confirm its status
DharānNepalUnknown status
Universidad Peruana Cayetano Heredia
Coordinator of this site? Confirm its status
PiuraPeruUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.